drugset / Trial / NCT00870103

Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery

NCT00870103

Phase 4 Completed 64 enrolled Alcon Research
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To demonstrate that the combination formulation of Moxifloxacin/Dexamethasone Eye Drop is effective and safe for the prevention of postoperative inflammation as a consequence of cataract extraction surgery.

Timeline

Start
2008-09
Primary completion
2009-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.1 % Other
Subject Moxifloxacin Small molecule 0.5 % Other

Indications